Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Frequency of Arterial Thromboemobolic Events in Patients with Cancer Associated Venous Thromboembolism

Doaa Attia, MD, Xuefei Jia, MS, Mailey L Wilks, DNP, MSN, APRN, Barbara Tripp, APRN, CNS, Christopher D'Andrea, PA-C, Keith R McCrae, MD, Alok A Khorana, MD, Dana E Angelini, MD

Blood (2020) 136 (Supplement 1): 37.

https://doi.org/10.1182/blood-2020-136101

Published: 2020

Journal Articles

Risk of Recurrent Venous Thromboembolism and Bleeding in Patients with Cancer Associated Thrombosis

Doaa Attia, MD, Xuefei Jia, MS, Mailey L Wilks, DNP, MSN, APRN, Barbara Tripp, APRN, CNS, Christopher D'Andrea, PA-C, Keith R McCrae, MD, Alok A Khorana, MD, Dana E Angelini, MD

Blood (2020) 136 (Supplement 1): 18.

https://doi.org/10.1182/blood-2020-142805

Published: 2020

Journal Articles

Deaths Due to Thrombotic Versus Bleeding Events within 90 Days of Cancer Associated Thrombosis

Mailey L Wilks, MSN, APRN, NP-C, Shyam K. Poudel, MD, Deborah Y. Park, BS, Xuefei Jia, MS, Vicki Pinkava, MSBS, PA-C, Meghan O'Brien, MS, ANP-BC, Barb Tripp, CNS, Jung-Min Song, RN,CNS, Keith R. McCrae, MD, Alok A. Khorana, MD, Dana E. Angelini, MD

Blood (2018) 132 (Supplement 1): 3570.

https://doi.org/10.1182/blood-2018-99-117338

Published: 2018

Journal Articles

Evaluating the Evidence for Long-Term Benefit from Specialty Centers Versus Real World for MDS Patients Treated with HMA

Sudipto Mukherjee, MD PhD MPH, Tomas Radivoyevitch, PhD, Brian P. Hobbs, PhD, Xuefei Jia, MS, Rami S. Komrokji, MD, David P. Steensma, MD, Amy E. DeZern, MD, Gail J. Roboz, MD, Guillermo Garcia-Manero, MD, Jaroslaw P. Maciejewski, Aziz Nazha, Mikkael A. Sekeres, MD MS

Blood (2018) 132 (Supplement 1): 3095.

https://doi.org/10.1182/blood-2018-99-119146

Published: 2018

Journal Articles

Does Trial Participation Improve Outcomes for Higher-Risk Myelodysplastic Syndromes (MDS) Patients Treated at Specialty Centers?

Sudipto Mukherjee, MD PhD MPH, David P. Steensma, MD, Rami S. Komrokji, MD, Amy E. DeZern, MD, Gail J. Roboz, MD, Guillermo Garcia-Manero, MD, Aziz Nazha, Jaroslaw P. Maciejewski, Mikkael A. Sekeres, MD MS, Brian P. Hobbs, PhD, Xuefei Jia, MS

Blood (2018) 132 (Supplement 1): 3096.

https://doi.org/10.1182/blood-2018-99-117174

Published: 2018

Journal Articles

Clinical Outcomes of Isolated Distal Deep Vein Thrombosis Associated with Cancer: The Cleveland Clinic Experience

Shyam K. Poudel, MD, Xuefei Jia, MS, Deborah Y. Park, BS, Mailey Lynn Wilks, CNP, MSN, APRN, Vicki Pinkava, MSBS, PA-C, Meghan O'Brien, MS, ANP-BC, Barbara Tripp, CNS, AOCN, Jung-Min Song, RN, CNS, Keith R. McCrae, MD, Alok A. Khorana, MD, Dana E. Angelini, MD

Blood (2018) 132 (Supplement 1): 4809.

https://doi.org/10.1182/blood-2018-99-114897

Published: 2018

Journal Articles

Impact of Venous Thromboembolism during High Intensity Chemotherapy for Acute Leukemia Patients on Duration of Hospital Stay

Madeline Waldron, PharmD, Caitlin Siebenaller, PharmD, Marc Earl, PharmD, Xuefei Jia, MS, Hetty E. Carraway, MD MBA, Anjali S. Advani, MD, Aziz Nazha, Aaron T. Gerds, MD MS, Betty K. Hamilton, MD, Ronald Sobecks, MD, Matt Kalaycio, MD, Barb Tripp, CNS, Brian P. Hobbs, PhD, Mikkael A. Sekeres, MD MS, Sudipto Mukherjee, MD PhD MPH

Blood (2018) 132 (Supplement 1): 4806.

https://doi.org/10.1182/blood-2018-99-115257

Published: 2018

Journal Articles

Clinical Outcomes with Direct Oral Anticoagulants Compared to Low Molecular Weight Heparins in the Treatment of Cancer-Associated Venous Thromboembolism

Deborah Y. Park, BS, Shyam K. Poudel, MD, Xuefei Jia, MS, Mailey Lynn Wilks, CNP, MSN, APRN, Vicki Pinkava, MSBS, PA-C, Meghan O'Brien, MS, ANP-BC, Barbara Tripp, CNS,AOCN, Jung-Min Song, RN,CNS, Keith R. McCrae, MD, Dana E. Angelini, MD, Alok A. Khorana, MD

Blood (2018) 132 (Supplement 1): 1237.

https://doi.org/10.1182/blood-2018-99-111897

Published: 2018

Journal Articles

Differences in Genomic Patterns between African Americans and Whites with Acute Myeloid Leukemia

Rachel Hu, MD, Aziz Nazha, Xuefei Jia, MS, Brian P. Hobbs, PhD, Hetty E. Carraway, MD MBA, Sudipto Mukherjee, MDPhDMPH, Aaron T. Gerds, MDMS, Anjali S. Advani, MD, Yasunobu Nagata, Cassandra M. Hirsch, Bartlomiej P. Przychodzen, Babal K. Jha, Jaroslaw P. Maciejewski, Mikkael A. Sekeres, MD MS

Blood (2018) 132 (Supplement 1): 1527.

https://doi.org/10.1182/blood-2018-99-114273

Published: 2018

Journal Articles

IPI, Comorbidity Index, Hospitalization for Treatment-Related Adverse Events Are Predictors for Outcome in Elderly Diffuse Large B Cell Lymphoma Patients

Caner Saygin, MD, Xuefei Jia, MS, Brian T. Hill, MD PhD, Robert M. Dean, MD, Bhumika Patel, MD, Brad Pohlman, MD, Mitchell R. Smith, Deepa Jagadeesh, MD MPH

Blood (2016) 128 (22): 1860.

https://doi.org/10.1182/blood.V128.22.1860.1860

Published: 2016

Journal Articles

Impact of Day 28 Absolute Lymphocyte Count on Outcome of Adult Patients with Acute Myeloid Leukemia

Naresh Bumma, MD, Jing Ai, MD PhD, Xuefei Jia, MS, Sean Hobson, MA, Donna Abounader, Mikkael A. Sekeres, MD MS, Matt E. Kalaycio, MD, Ron Sobecks, MD, Aaron Gerds, MDMS, Betty K. Hamilton, MD, Sudipto Mukherjee, MD PhD MPH, Hetty E. Carraway, MD, Shawnda Tench, Edward A. Copelan, MD, Anjali S. Advani, MD

Blood (2014) 124 (21): 5256.

https://doi.org/10.1182/blood.V124.21.5256.5256

Published: 2014

NARROW

Frequency of Arterial Thromboemobolic Events in Patients with Cancer Associated Venous Thromboembolism

Risk of Recurrent Venous Thromboembolism and Bleeding in Patients with Cancer Associated Thrombosis

Deaths Due to Thrombotic Versus Bleeding Events within 90 Days of Cancer Associated Thrombosis

Evaluating the Evidence for Long-Term Benefit from Specialty Centers Versus Real World for MDS Patients Treated with HMA

Does Trial Participation Improve Outcomes for Higher-Risk Myelodysplastic Syndromes (MDS) Patients Treated at Specialty Centers?

Clinical Outcomes of Isolated Distal Deep Vein Thrombosis Associated with Cancer: The Cleveland Clinic Experience

Impact of Venous Thromboembolism during High Intensity Chemotherapy for Acute Leukemia Patients on Duration of Hospital Stay

Clinical Outcomes with Direct Oral Anticoagulants Compared to Low Molecular Weight Heparins in the Treatment of Cancer-Associated Venous Thromboembolism

Differences in Genomic Patterns between African Americans and Whites with Acute Myeloid Leukemia

IPI, Comorbidity Index, Hospitalization for Treatment-Related Adverse Events Are Predictors for Outcome in Elderly Diffuse Large B Cell Lymphoma Patients

Impact of Day 28 Absolute Lymphocyte Count on Outcome of Adult Patients with Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only